Atlassian Overview
Atlassian Target Price
See Atlassian's analyst price targets ($160) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$186.44
Average Target Price
$163.25
12.4% downside
12.4% downside20 analysts in the last 4 months
High: $215 | Low: $95
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-25 | RBC Capital | $215 |  15.3% upside |  |
| 2026-08-20 | Truist Financial | $185 | 0.8% downside | |
| 2026-08-10 | FBN SecuritiesShebly Seyrafi | $170 | 8.8% downside | |
| 2026-08-10 | Barclays | $172 | 7.7% downside | |
| 2026-08-07 | BMO Capital | $175 | 6.1% downside | |
| 2026-08-07 | BTIGAllan Verkhovski | $180 | 3.5% downside | |
| 2026-08-07 | Guggenheim | $165 | 11.5% downside | |
| 2026-08-07 | Raymond James | $180 | 3.5% downside | |
| 2026-08-07 | Wells FargoRyan MacWilliams | $180 | 3.5% downside | |
| 2026-08-07 | Morgan Stanley | $180 | 3.5% downside | |
| 2026-08-07 | Truist Financial | $160 | 14.2% downside | |
| 2026-08-07 | KeyBanc | $185 | 0.8% downside | |
| 2026-08-07 | JefferiesBrent Thill | $200 | 7.3% upside | |
| 2026-08-07 | Robert W. BairdRob Oliver | $200 | 7.3% upside | |
| 2026-08-07 | UBS | $160 | 14.2% downside | |
| 2026-08-03 | Cantor FitzgeraldThomas Blakey | $126 | 32.4% downside | |
| 2026-07-08 | KeyBanc | $115 | 38.3% downside | |
| 2026-06-25 | BMO Capital | $95 | 49% downside | |
| 2026-05-11 | Oppenheimer | $110 | 41% downside | |
| 2026-05-07 | Barclays | $112 | 39.9% downside | |
| 2026-05-01 | Robert W. BairdRob Oliver | $120 | 35.6% downside | |
| 2026-05-01 | Cantor FitzgeraldThomas Blakey | $107 | 42.6% downside | |
| 2026-05-01 | Barclays | $106 | 43.1% downside | |
| 2026-05-01 | Raymond James | $130 | 30.3% downside | |
| 2026-05-01 | BTIG | $120 | 35.6% downside | |
| 2026-05-01 | Truist Financial | $100 | 46.4% downside | |
| 2026-05-01 | BernsteinPeter Weed | $295 | 58.2% upside | |
| 2026-04-27 | Cantor FitzgeraldThomas Blakey | $98 | 47.4% downside | |
| 2026-04-20 | Barclays | $100 | 46.4% downside | |
| 2026-04-17 | Oppenheimer | $100 | 46.4% downside | |
| 2026-04-16 | Morgan StanleyKeith Weiss | $120 | 35.6% downside | |
| 2026-04-15 | Truist Financial | $90 | 51.7% downside | |
| 2026-04-15 | Canaccord Genuity | $150 | 19.5% downside | |
| 2026-04-14 | Mizuho Securities | $145 | 22.2% downside | |
| 2026-04-09 | Guggenheim | $115 | 38.3% downside | |
| 2026-03-12 | Mizuho SecuritiesGreg Moskowitz | $185 | 0.8% downside | |
| 2026-03-12 | Wolfe ResearchAlex Zukin | $100 | 46.4% downside | |
| 2026-02-06 | Barclays | $165 | 11.5% downside | |
| 2026-02-06 | UBSKarl Keirstead | $105 | 43.7% downside | |
| 2026-02-06 | Jefferies | $150 | 19.5% downside | |
| 2026-02-06 | Canaccord GenuityDavid Hynes | $185 | 0.8% downside | |
| 2026-02-06 | Piper Sandler | $200 | 7.3% upside | |
| 2026-02-06 | KeyBancJason Celino | $170 | 8.8% downside | |
| 2026-02-06 | Mizuho SecuritiesGregg Moskowitz | $205 | 10% upside | |
| 2026-02-06 | BTIG | $140 | 24.9% downside | |
| 2026-02-06 | Wells FargoRyan MacWilliams | $155 | 16.9% downside | |
| 2026-02-06 | Oppenheimer | $150 | 19.5% downside | |
| 2026-02-06 | BMO CapitalKeith Bachman | $130 | 30.3% downside | |
| 2026-02-06 | Morgan Stanley | $290 | 55.5% upside | |
| 2026-02-06 | Robert W. Baird | $140 | 24.9% downside | |